Skip to menu Skip to content Skip to footer

2015

Conference Publication

Adoptive T-Cell Immunotherapy for Treatment of Ganciclovir-Resistant Cmv Disease After Lung Transplantation

Holmes-Liew, C., Holmes, M., Beagley, L., Hopkins, P., Chambers, D., Smith, C. and Khanna, R. (2015). Adoptive T-Cell Immunotherapy for Treatment of Ganciclovir-Resistant Cmv Disease After Lung Transplantation. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science, Annual Scientific Meeting 2015, Queensland, Australia, 27 March–1 April 2015. Malden MA United States: Wiley-Blackwell.

Adoptive T-Cell Immunotherapy for Treatment of Ganciclovir-Resistant Cmv Disease After Lung Transplantation

2015

Conference Publication

Hyaluronan - the First New Biomarker of Donor Organ Quality Since Po2?

Sladden, T., Samson, L., Hopkins, P., Yerkovich, S. and Chambers, D. (2015). Hyaluronan - the First New Biomarker of Donor Organ Quality Since Po2?. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science, Annual Scientific Meeting 2015, Queensland, Australia, 27 March–1 April 2015. Malden MA United States: Wiley-Blackwell.

Hyaluronan - the First New Biomarker of Donor Organ Quality Since Po2?

2014

Journal Article

Advanced therapies for COPD-what's on the horizon? Progress in lung volume reduction and lung transplantation

Trotter, Michael A. and Hopkins, Peter M. (2014). Advanced therapies for COPD-what's on the horizon? Progress in lung volume reduction and lung transplantation. Journal of Thoracic Disease, 6 (11), 1640-1653. doi: 10.3978/j.issn.2072-1439.2014.11.34

Advanced therapies for COPD-what's on the horizon? Progress in lung volume reduction and lung transplantation

2014

Journal Article

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis

King, Talmadge E., Bradford, Williamson Z., Castro-Bernardini, Socorro, Fagan, Elizabeth A., Glaspole, Ian, Glassberg, Marilyn K., Gorina, Eduard, Hopkins, Peter M., Kardatzke, David, Lancaster, Lisa, Lederer, David J., Nathan, Steven D., Pereira, Carlos A., Sahn, Steven A., Sussman, Robert, Swigris, Jeffrey J. and Noble, Paul W. (2014). A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. New England Journal of Medicine, 370 (22), 2083-2092. doi: 10.1056/NEJMoa1402582

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis

2014

Journal Article

Prevalence and prognosis of unclassifiable interstitial lung disease

Troy, Lauren, Glaspole, Ian, Goh, Nicole, Zappala, Chris, Hopkins, Peter, Wilsher, Margaret, Moodiey, Yuben and Corte, Tamera (2014). Prevalence and prognosis of unclassifiable interstitial lung disease. European Respiratory Journal, 43 (5), 1529-1530. doi: 10.1183/09031936.00003414

Prevalence and prognosis of unclassifiable interstitial lung disease

2014

Conference Publication

DYSREGULATED REPAIR AND EPITHELIAL INJURY IN SMALL AND LARGE AIRWAYS OF LUNG TRANSPLANT PATIENTS IS AMELIORATED BY AZITHROMYCIN

Kicic, A., Lavender, M., Musk, M., Wrobel, J., Banerjee, B., Ling, K., Martinovich, K., Garratt, L., Iosifidis, T., Looi, K., Kicic-Starvevich, E., Lannigan, F., Hopkins, P., Yerkovich, S., Sutanto, E., Chambers, D. and Stick, S. (2014). DYSREGULATED REPAIR AND EPITHELIAL INJURY IN SMALL AND LARGE AIRWAYS OF LUNG TRANSPLANT PATIENTS IS AMELIORATED BY AZITHROMYCIN. HOBOKEN: WILEY-BLACKWELL. doi: 10.1111/resp.12264

DYSREGULATED REPAIR AND EPITHELIAL INJURY IN SMALL AND LARGE AIRWAYS OF LUNG TRANSPLANT PATIENTS IS AMELIORATED BY AZITHROMYCIN

2014

Conference Publication

A Phase 1B Study of Mesenchymal Stromal Cell Therapy for Idiopathic Pulmonary Fibrosis

Chambers, D. C., Enever, D., Ilic, N., Sparks, L., Ayres, J., Yerkovich, S. T., Khalil, D., Atkinson, K. and Hopkins, P. M. (2014). A Phase 1B Study of Mesenchymal Stromal Cell Therapy for Idiopathic Pulmonary Fibrosis. ISCT 2014 Annual Meeting, Paris France, April 23-26 2014. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jcyt.2014.01.029

A Phase 1B Study of Mesenchymal Stromal Cell Therapy for Idiopathic Pulmonary Fibrosis

2014

Conference Publication

Erratic tacrolimus blood levels are associated with bronchiolitis obliterans syndrome (BOS) and death after lung transplantation

Gallagher, H. M., Sarwar, G., Tse, T., Sladden, T. J., Yerkovich, S. T., Hopkins, P. M. and Chambers, D. C. (2014). Erratic tacrolimus blood levels are associated with bronchiolitis obliterans syndrome (BOS) and death after lung transplantation. 34th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation, San Diego, CA, United States, 10-13 April 2014. Philadelphia, PA, United States: Elsevier . doi: 10.1016/j.healun.2014.01.216

Erratic tacrolimus blood levels are associated with bronchiolitis obliterans syndrome (BOS) and death after lung transplantation

2014

Conference Publication

Endothelial Glycocalyx Integrity Is Critical To Organ Function During Human Ex-Vivo Lung Perfusion

Chambers, D. C., Hunt, W., Smith, I. J., Samson, L., Sladden, T. M., Yerkovich, S., Naidoo, R., Wall, D. and Hopkins, P. M. (2014). Endothelial Glycocalyx Integrity Is Critical To Organ Function During Human Ex-Vivo Lung Perfusion. 34th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation, San Diego CA, United States, Apr 10-13, 2014. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.healun.2014.01.072

Endothelial Glycocalyx Integrity Is Critical To Organ Function During Human Ex-Vivo Lung Perfusion

2014

Journal Article

A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis

Chambers, Daniel C., Enever, Debra, Ilic, Nina, Sparks, Lisa, Whitelaw, Kylie, Ayres, John, Yerkovich, Stephanie T., Khalil, Dalia, Atkinson, Kerry M. and Hopkins, Peter M. A. (2014). A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis. Respirology, 19 (7), 1013-1018. doi: 10.1111/resp.12343

A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis

2014

Conference Publication

Comparison of voriconazole and posaconazole use in lung transplant patients

Chau, C., Stephanie, Y., Tse, T., Hopkins, P., Henning, S. and Chambers, D. (2014). Comparison of voriconazole and posaconazole use in lung transplant patients. 34th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation, San Diego, CA, United States, 10-13 April 2014. Philadelphia, PA, United States: Elsevier . doi: 10.1016/j.healun.2014.01.782

Comparison of voriconazole and posaconazole use in lung transplant patients

2013

Journal Article

Idiopathic pulmonary fibrosis: a degenerative disease requiring a regenerative approach

Chambers, Daniel C. and Hopkins, Peter M. A. (2013). Idiopathic pulmonary fibrosis: a degenerative disease requiring a regenerative approach. American Journal of Respiratory and Critical Care Medicine, 188 (2), 252-253. doi: 10.1164/rccm.201301-0192LE

Idiopathic pulmonary fibrosis: a degenerative disease requiring a regenerative approach

2013

Journal Article

Impaired exercise capacity after lung transplantation is related to delayed recovery of muscle strength

Walsh, James R., Chambers, Daniel C., Davis, Rebecca J., Morris, Norman R., Seale, Helen E., Yerkovich, Stephanie T. and Hopkins, Peter M. A. (2013). Impaired exercise capacity after lung transplantation is related to delayed recovery of muscle strength. Clinical Transplantation, 27 (4), E504-E511. doi: 10.1111/ctr.12163

Impaired exercise capacity after lung transplantation is related to delayed recovery of muscle strength

2013

Journal Article

Life-Saving Closure of a Pulmonary Cavity by Endobronchial Valve Placement

Fielding, David I., Bashirzadeh, Farzad, Deller, David, Douglas, Alexandra, Boots, Robert and Hopkins, Peter (2013). Life-Saving Closure of a Pulmonary Cavity by Endobronchial Valve Placement. American Journal of Respiratory and Critical Care Medicine, 187 (10), 1145-1146. doi: 10.1164/rccm.201210-1833LE

Life-Saving Closure of a Pulmonary Cavity by Endobronchial Valve Placement

2013

Journal Article

Australia’s experience with ex-vivo lung perfusion of highly marginal donors

Hopkins, P. M., Chambers, D. C., Naidoo, R., Wall, D. A., Smith, I. J. and Hunt, W. G. (2013). Australia’s experience with ex-vivo lung perfusion of highly marginal donors. The Journal of Heart and Lung Transplantation, 32 (4), S154. doi: 10.1016/j.healun.2013.01.355

Australia’s experience with ex-vivo lung perfusion of highly marginal donors

2013

Conference Publication

Australia's experience with Ex-Vivo lung perfusion of highly marginal donors

Hopkins, P. M., Chambers, D. C., Naidoo, R., Wall, D. A., Smith, I. J. and Hunt, W. G. (2013). Australia's experience with Ex-Vivo lung perfusion of highly marginal donors. 33rd Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation, Montreal Canada, 24-27 April 2013. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.healun.2013.01.355,

Australia's experience with Ex-Vivo lung perfusion of highly marginal donors

2013

Conference Publication

Transbronchial Brush (TBBr) detection of activated T Cells identifies patients at risk of progressive Bronchiolitis Obliterans Syndrome (BOS)

Chambers, D. C., Fiene, A., Sinclair, K., Samson, L., Tan, M. E., Sladden, T., Hopkins, P. M. A. and Yerkovich, S. T. (2013). Transbronchial Brush (TBBr) detection of activated T Cells identifies patients at risk of progressive Bronchiolitis Obliterans Syndrome (BOS). 33rd Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation, Montreal Canada, 24-27 April 2013. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.healun.2013.01.1027

Transbronchial Brush (TBBr) detection of activated T Cells identifies patients at risk of progressive Bronchiolitis Obliterans Syndrome (BOS)

2013

Conference Publication

Safety of a mesenchymal-like Adherent Stromal Cell (PLX-PAD) in a human model of Pulmonary Arterial Hypertension (PAH)

Chambers, D. C., Hunt, W., Naidoo, R., Wall, D., Choudhary, J., Enever, D. L., Samson, L., Yerkovich, S. T., Rapchuk, I. L., Smith, I. J., Hopkins, P. M. A. and Kermeen, F. D. (2013). Safety of a mesenchymal-like Adherent Stromal Cell (PLX-PAD) in a human model of Pulmonary Arterial Hypertension (PAH). 33rd Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation, Montreal Canada, 24-27 April 2013. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.healun.2013.01.977

Safety of a mesenchymal-like Adherent Stromal Cell (PLX-PAD) in a human model of Pulmonary Arterial Hypertension (PAH)

2013

Conference Publication

Poor adherence to photoprotection and skin surveillance: Recommendations in lung transplant recipients

Morze, C., Sahebian, A., Grant, M., Hopkins, P. M. A., Yerkovich, S. T., Chambers, D. C. C. and Soyer, H. P. (2013). Poor adherence to photoprotection and skin surveillance: Recommendations in lung transplant recipients. The Australasian College of Dermatologists 46th Annual Scientific Meeting, Sydney, New South Wales, 19–22 May 2013. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.12051

Poor adherence to photoprotection and skin surveillance: Recommendations in lung transplant recipients

2013

Conference Publication

Distinct lymphocyte subsets infiltrate the small and large airway epithelium after lung transplantation

Yerkovich, S. T., Fiene, A., Sinclair, K., Tan, M., Samson, L., Hopkins, P. M. A. and Chambers, D. C. (2013). Distinct lymphocyte subsets infiltrate the small and large airway epithelium after lung transplantation. 33rd Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation, Montreal Canada, 24-27 April 2013. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.healun.2013.01.189

Distinct lymphocyte subsets infiltrate the small and large airway epithelium after lung transplantation